M&A · Healthcare · Buyer's industry: Biological Products, (No Diagnostic Substances)
Eloxx Pharmaceuticals, Inc. to acquire Zikani Therapeutics
Announced Apr 1, 2021 · Closed Apr 1, 2021 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- Eloxx Pharmaceuticals, Inc. (ELOX)
- Target
- Zikani Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Apr 1, 2021
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Biological Products, (No Diagnostic Substances)